Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts $748.01 -1.91 (-0.25%) (As of 11/22/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Eli Lilly and Company Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 4EstimatedActual EPS (Oct. 30) $1.18 Missed By -$0.34 Consensus EPS (Oct. 30) $1.52 Eli Lilly and Company announced Q3 2024 earnings on October 30, 2024, reporting an EPS of $1.18, which missed the consensus estimate of $1.52 by $0.34. Quarterly revenue rose 20.4% year-over-year to $11.44 billion, below analysts' expectations of $12.09 billion. With a trailing EPS of $9.25 and a P/E Ratio of 80.87, Eli Lilly and Company's earnings are expected to grow 78.94% next year, from $13.20 to $23.62 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckSEC 10-Q/10-K FilingLLY Upcoming EarningsEli Lilly and Company's next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules. Get Eli Lilly and Company Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eli Lilly and Company and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLLY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LLY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Eli Lilly and Company Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$2.34$2.74$2.54 Q2 20243$2.41$2.89$2.64 Q3 20243$1.24$4.39$2.85 Q4 20243$3.04$5.52$4.67 FY 202412$9.03$15.54$12.70 Q1 20251$4.70$4.70$4.70 Q2 20251$5.24$5.24$5.24 Q3 20251$6.19$6.19$6.19 Q4 20251$6.73$6.73$6.73 FY 20254$22.86$22.86$22.86 Q1 20261$6.14$6.14$6.14 Q2 20261$6.90$6.90$6.90 Q3 20261$7.93$7.93$7.93 Eli Lilly and Company Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/4/2025(Estimated)------- 10/30/2024Q3 2024$1.52$1.18 -$0.34$1.29$12.09B$11.44B 8/8/2024Q2 2024$2.64$3.92+$1.28$4.56$9.83B$11.30B5/6/2024Q1 2024$2.53$2.58+$0.05$2.68$8.94B$8.77B 2/6/2024Q4 2023$2.30$2.49+$0.19$2.56$8.95B$9.35B 11/2/2023Q3 2023-$0.08$0.10+$0.18$0.26$8.88B$9.50B 8/8/2023Q2 2023$1.98$2.11+$0.13$2.27$7.58B$8.31B Ever heard of this 8-day bitcoin profit window? (Ad)Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. 4/27/2023Q1 2023$1.73$1.62 -$0.11$1.75$6.87B$6.96B 2/2/2023Q4 2022$1.83$2.09+$0.26$2.04$7.39B$7.30B Eli Lilly and Company Earnings - Frequently Asked Questions When is Eli Lilly and Company's earnings date? Eli Lilly and Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on LLY's earnings history. What guidance has Eli Lilly and Company issued on next quarter's earnings? Eli Lilly and Company updated its FY24 earnings guidance on Wednesday, October, 30th. The company provided EPS guidance of $13.02-13.52 for the period, compared to the consensus estimate of $13.42. The company issued revenue guidance of $45.4-46.0 billion, compared to the consensus revenue estimate of $46.24 billion. Did Eli Lilly and Company beat their earnings estimates last quarter? In the previous quarter, Eli Lilly and Company (NYSE:LLY) missed the analysts' consensus estimate of $1.52 by $0.34 with a reported earnings per share (EPS) of $1.18. Learn more on analysts' earnings estimate vs. LLY's actual earnings. How can I listen to Eli Lilly and Company's earnings conference call? The conference call for Eli Lilly and Company's latest earnings report can be listened to online. Listen to Conference Call How can I read Eli Lilly and Company's conference call transcript? The conference call transcript for Eli Lilly and Company's latest earnings report can be read online. Read Transcript How can I view Eli Lilly and Company's earnings report? Eli Lilly and Company's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $34.12 billion. How much profit does Eli Lilly and Company generate each year? Eli Lilly and Company (NYSE:LLY) has a recorded net income of $5.24 billion. LLY has generated $9.25 earnings per share over the last four quarters. What is Eli Lilly and Company's price-to-earnings ratio? Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 80.87 and a forward price-to-earnings ratio of 56.67. The price/earnings-to-growth ratio is 2.84. What is Eli Lilly and Company's EPS forecast for next year? Eli Lilly and Company's earnings are expected to grow from $13.20 per share to $23.62 per share in the next year, which is a 78.94% increase. ` More Earnings Resources from MarketBeat Related Companies Johnson & Johnson Earnings Results AbbVie Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Bristol-Myers Squibb Earnings Results Zoetis Earnings Results Royalty Pharma Earnings Results Jazz Pharmaceuticals Earnings Results Corcept Therapeutics Earnings Results Perrigo Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A “Thank You Gift” From Pres. Trump - Genius (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide This page (NYSE:LLY) was last updated on 11/24/2024 by MarketBeat.com Staff From Our Partners[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eli Lilly and Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Eli Lilly and Company With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LLY Stock Alerts